Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Announces Quarterly Earnings Results

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) posted its quarterly earnings data on Wednesday. The company reported $0.91 earnings per share (EPS) for the quarter, Zacks reports. Recordati Industria Chimica E Farmaceutica had a net margin of 17.81% and a return on equity of 34.38%.

Recordati Industria Chimica E Farmaceutica Price Performance

OTCMKTS:RCDTF remained flat at $58.00 during trading hours on Wednesday. The firm has a 50 day simple moving average of $58.63 and a 200 day simple moving average of $59.46. Recordati Industria Chimica E Farmaceutica has a one year low of $55.88 and a one year high of $60.00. The company has a current ratio of 1.26, a quick ratio of 0.86 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $11.97 billion, a P/E ratio of 21.94 and a beta of 0.25.

About Recordati Industria Chimica E Farmaceutica

Recordati Industria Chimica e Farmaceutica is an Italy‐based international pharmaceutical company engaged in the research, development, manufacturing and commercialization of therapeutic products. Established in 1926, the company has built a diversified portfolio that includes proprietary drugs, generics and orphan medicines, with a particular emphasis on treatments for rare diseases. Recordati’s product range spans cardiovascular, urology, endocrinology, dermatology and oncology therapies, as well as specialized formulations for genetic and metabolic disorders.

The company’s historical roots date back nearly a century, when it began as a family‐owned enterprise in Milan.